Artificial intelligence guided discovery of a barrier-protective therapy in inflammatory bowel disease

[1]  Stella-Rita C. Ibeawuchi,et al.  The stress polarity signaling (SPS) pathway serves as a marker and a target in the leaky gut barrier: implications in aging and cancer , 2020, Life Science Alliance.

[2]  M. Murad,et al.  First- and Second-line Pharmacotherapies for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis. , 2020, Clinical Gastroenterology and Hepatology.

[3]  Wooseong Kim,et al.  Mesalazine activates adenosine monophosphate-activated protein kinase: Implication in the anti-inflammatory activity of this anti-colitic drug. , 2019, Current molecular pharmacology.

[4]  H. Morita,et al.  Berberine improved experimental chronic colitis by regulating interferon-γ- and IL-17A-producing lamina propria CD4+ T cells through AMPK activation , 2019, Scientific Reports.

[5]  S. Vermeire,et al.  Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease , 2019, EBioMedicine.

[6]  Qiang Xu,et al.  Activating AMPK to Restore Tight Junction Assembly in Intestinal Epithelium and to Attenuate Experimental Colitis by Metformin , 2018, Front. Pharmacol..

[7]  M. Du,et al.  AMPK in regulation of apical junctions and barrier function of intestinal epithelium , 2018, Tissue barriers.

[8]  Stella-Rita C. Ibeawuchi,et al.  Dysregulation of the engulfment pathway in the gut fuels Inflammatory Bowel Disease , 2018, bioRxiv.

[9]  D. Sahoo,et al.  Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer , 2018, Oncotarget.

[10]  C. Gelfi,et al.  Contribution of Extracellular Matrix and Signal Mechanotransduction to Epithelial Cell Damage in Inflammatory Bowel Disease Patients: A Proteomic Study , 2017, Proteomics.

[11]  Andrea Califano,et al.  Systematic, network-based characterization of therapeutic target inhibitors , 2017, PLoS Comput. Biol..

[12]  K. Hao,et al.  A functional genomics predictive network model identifies regulators of inflammatory bowel disease , 2017, Nature Genetics.

[13]  T. Phan,et al.  Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing. , 2017, Gastroenterology.

[14]  Xinying Xu,et al.  An Ameliorated Prediction of Drug–Target Interactions Based on Multi-Scale Discrete Wavelet Transform and Network Features , 2017, International journal of molecular sciences.

[15]  Mei-Jun Zhu,et al.  AMP-activated protein kinase: a therapeutic target in intestinal diseases , 2017, Open Biology.

[16]  R. Kurumbail,et al.  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy , 2017, The Journal of Pharmacology and Experimental Therapeutics.

[17]  M. Donowitz,et al.  A primary human macrophage-enteroid co-culture model to investigate mucosal gut physiology and host-pathogen interactions , 2017, Scientific Reports.

[18]  Ming Xu,et al.  Geniposide ameliorates TNBS-induced experimental colitis in rats via reducing inflammatory cytokine release and restoring impaired intestinal barrier function , 2017, Acta Pharmacologica Sinica.

[19]  M. Du,et al.  AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression , 2017, Cell Death and Differentiation.

[20]  Bo Wang,et al.  Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results. , 2016, JAMA internal medicine.

[21]  I. Kufareva,et al.  AMP-activated protein kinase fortifies epithelial tight junctions during energetic stress via its effector GIV/Girdin , 2016, eLife.

[22]  Damian Szklarczyk,et al.  The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..

[23]  P. Rutgeerts,et al.  Effect of vedolizumab (anti-α4β7-integrin) therapy on histological healing and mucosal gene expression in patients with UC , 2016, Gut.

[24]  Jessica Ward,et al.  Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy. , 2016, Journal of medicinal chemistry.

[25]  Yansong Xue,et al.  Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice , 2016, PloS one.

[26]  J. Scannell,et al.  When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis , 2016, PloS one.

[27]  D. Sahoo,et al.  CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. , 2016, The New England journal of medicine.

[28]  L. Eckmann,et al.  Regulation of Rac1 and Reactive Oxygen Species Production in Response to Infection of Gastrointestinal Epithelia , 2016, PLoS pathogens.

[29]  A. del Sol,et al.  Prediction of disease–gene–drug relationships following a differential network analysis , 2016, Cell Death and Disease.

[30]  R. Uwiera,et al.  Animal models to study acute and chronic intestinal inflammation in mammals , 2015, Gut Pathogens.

[31]  Isabelle Cleynen,et al.  Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease , 2015, Inflammatory bowel diseases.

[32]  Judy H. Cho,et al.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.

[33]  Jinshui Fan,et al.  Mobilization of epithelial mesenchymal transition genes distinguishes active from inactive lesional tissue in patients with ulcerative colitis. , 2015, Human molecular genetics.

[34]  M. Bøgsted,et al.  Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies , 2015, Inflammatory bowel diseases.

[35]  M. Helmrath,et al.  Establishment of Human Epithelial Enteroids and Colonoids from Whole Tissue and Biopsy , 2015, Journal of visualized experiments : JoVE.

[36]  E. E. Vincent,et al.  The energy sensor AMPK regulates T cell metabolic adaptation and effector responses in vivo. , 2015, Immunity.

[37]  J. Florholmen.  Mucosal healing in the era of biologic agents in treatment of inflammatory bowel disease , 2015, Scandinavian journal of gastroenterology.

[38]  P. Rutgeerts,et al.  Integrated miRNA and mRNA Expression Profiling in Inflamed Colon of Patients with Ulcerative Colitis , 2014, PloS one.

[39]  Rainer Breitling,et al.  TrypanoCyc: a community-led biochemical pathways database for Trypanosoma brucei , 2014, Nucleic Acids Res..

[40]  Jung Mogg Kim,et al.  Anti‐inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis‐associated colon cancer , 2014, Journal of gastroenterology and hepatology.

[41]  B. Chassaing,et al.  Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice , 2014, Current protocols in immunology.

[42]  David Carling,et al.  Structural basis of AMPK regulation by small molecule activators , 2013, Nature Communications.

[43]  M. Ramanathan,et al.  Network‐Based Approaches in Drug Discovery and Early Development , 2013, Clinical pharmacology and therapeutics.

[44]  Henning Hermjakob,et al.  The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..

[45]  Hiroyuki Miyoshi,et al.  In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture , 2013, Nature Protocols.

[46]  W. Fries,et al.  Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions. , 2013, Current drug targets.

[47]  L. Tran,et al.  Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease , 2013, Cell.

[48]  M. Westerhoff,et al.  Gene Signature Distinguishes Patients with Chronic Ulcerative Colitis Harboring Remote Neoplastic Lesions , 2013, Inflammatory bowel diseases.

[49]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[50]  I. Jurisica,et al.  Network-based characterization of drug-regulated genes, drug targets, and toxicity. , 2012, Methods.

[51]  J. Ahluwalia.  Immunotherapy in inflammatory bowel disease. , 2012, The Medical clinics of North America.

[52]  D. Sahoo.  The Power of Boolean Implication Networks , 2012, Front. Physio..

[53]  Rachel B. Brem,et al.  Stitching together Multiple Data Dimensions Reveals Interacting Metabolomic and Transcriptomic Networks That Modulate Cell Regulation , 2012, PLoS biology.

[54]  W. Khan,et al.  Investigating intestinal inflammation in DSS-induced model of IBD. , 2012, Journal of visualized experiments : JoVE.

[55]  Jens-Peter Volkmer,et al.  Three differentiation states risk-stratify bladder cancer into distinct subtypes , 2012, Proceedings of the National Academy of Sciences.

[56]  R. Kiesslich,et al.  Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease , 2011, Gut.

[57]  A. Barabasi,et al.  Systems biology and the future of medicine , 2011, Wiley interdisciplinary reviews. Systems biology and medicine.

[58]  Pradeep S Rajendran,et al.  Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.

[59]  C. Bernstein,et al.  AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis. , 2010, Biochemical pharmacology.

[60]  Kristel Van Steen,et al.  Predictive value of epithelial gene expression profiles for response to infliximab in Crohn's disease‡ , 2010, Inflammatory bowel diseases.

[61]  Debashis Sahoo,et al.  MiDReG: A method of mining developmentally regulated genes using Boolean implications , 2010, Proceedings of the National Academy of Sciences.

[62]  Isabelle Cleynen,et al.  Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment , 2009, PloS one.

[63]  B. Viollet,et al.  AMP-Activated Protein Kinase–Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol , 2009, Diabetes.

[64]  Le Shen,et al.  Mechanisms and Functional Implications of Intestinal Barrier Defects , 2009, Digestive Diseases.

[65]  D. Sahoo,et al.  Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development. , 2009, Genes & development.

[66]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[67]  S. Friend,et al.  A network view of disease and compound screening , 2009, Nature Reviews Drug Discovery.

[68]  Robert Tibshirani,et al.  Boolean implication networks derived from large scale, whole genome microarray datasets , 2008, Genome Biology.

[69]  M. Farquhar,et al.  Activation of Gαi3 triggers cell migration via regulation of GIV , 2008, The Journal of cell biology.

[70]  P. Csermely.  Creative elements: network-based predictions of active centres in proteins and cellular and social networks. , 2008, Trends in biochemical sciences.

[71]  Debashis Sahoo,et al.  Extracting binary signals from microarray time-course data , 2007, Nucleic acids research.

[72]  Dennis B. Troup,et al.  NCBI GEO: mining tens of millions of expression profiles—database and tools update , 2006, Nucleic Acids Res..

[73]  Adam A. Margolin,et al.  Reverse engineering cellular networks , 2006, Nature Protocols.

[74]  M. Farquhar,et al.  Identification and Characterization of GIV, a Novel Gαi/s -interacting Protein Found on COPI, Endoplasmic Reticulum-Golgi Transport Vesicles* , 2005, Journal of Biological Chemistry.

[75]  Shailesh V. Date,et al.  A Probabilistic Functional Network of Yeast Genes , 2004, Science.

[76]  E. Koonin,et al.  Conservation and coevolution in the scale-free human gene coexpression network. , 2004, Molecular biology and evolution.

[77]  Chris Wiggins,et al.  ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.

[78]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[79]  M. Reinders,et al.  Genetic network modeling. , 2002, Pharmacogenomics.

[80]  I S Kohane,et al.  Mutual information relevance networks: functional genomic clustering using pairwise entropy measurements. , 1999, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[81]  G. Corrao,et al.  Intestinal permeability test as a predictor of clinical course in Crohn's disease , 1999, American Journal of Gastroenterology.

[82]  J. Boudeau,et al.  Invasive Ability of an Escherichia coliStrain Isolated from the Ileal Mucosa of a Patient with Crohn’s Disease , 1999, Infection and Immunity.

[83]  G. Church,et al.  Systematic determination of genetic network architecture , 1999, Nature Genetics.

[84]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[85]  N. Gulbahce,et al.  Network medicine: a network-based approach to human disease , 2010, Nature Reviews Genetics.

[86]  Judy H Cho,et al.  Inflammatory bowel disease. , 2009, The New England journal of medicine.

[87]  G. Sumara,et al.  A Probabilistic Functional Network of Yeast Genes , 2004 .

[88]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..